Sonnet BioTherapeutic News

Sonnet BioTherapeutic | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 26 17:18 ET

Sonnet BioTherapeutic | 8-K: Current report

Nov 8 08:34 ET

Sonnet BioTherapeutic | 424B4: Prospectus

Nov 7 09:23 ET

Sonnet BioTherapeutic | EFFECT: Others

Nov 7 06:08 ET

Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Nov 6 09:27 ET

Sonnet BioTherapeutic | 8-K: Current report

Nov 6 08:52 ET

Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Nov 4 09:04 ET

Sonnet BioTherapeutic | S-1: General form for registration of securities under the Securities Act of 1933

Oct 28 09:04 ET

Sonnet BioTherapeutic | 8-K: Current report

Oct 17 08:55 ET

Sonnet BioTherapeutic | 8-K: Current report

Oct 9 09:01 ET

Sonnet BioTherapeutic | 8-K: Current report

Sep 30 08:33 ET

Sonnet BioTherapeutic | 8-K: Current report

Sep 18 08:37 ET

Sonnet BioTherapeutic | 8-K: Current report

Sep 12 17:19 ET

Sonnet BioTherapeutic | 8-K: Current report

Sep 9 16:11 ET

Sonnet BioTherapeutic | 8-K: Current report

Aug 30 08:32 ET

Sonnet BioTherapeutic | ARS: Annual Report to Security Holders

Aug 19 17:33 ET

Sonnet BioTherapeutic | DEF 14A: Definitive information statements

Aug 19 17:28 ET

Sonnet BioTherapeutic | 8-K: Current report

Aug 19 08:52 ET

Sonnet BioTherapeutic | 10-Q: Q3 2024 Earnings Report

Aug 14 08:49 ET

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Aug 14 08:44 ET